Biotechnology News

July 13, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act...

July 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2012 following the close of market on Tuesday, July 24, 2012. On the same day, at 2:00pm Pacific Time (5:00pm Eastern Time) Jay...

July 12, 2012

OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec Moves Forward on Pharmaceutical Transdermal Delivery

July 12, 2012

LYON, France--(BUSINESS WIRE)--Regulatory News: The MEDICREA Group (FR0004178572-ALMED), listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal...

July 12, 2012

MADISON, Wis.--(BUSINESS WIRE)--Two of the nation’s top life science CEOs set to keynote BioForward’s 25th Annual Bioscience Vision Summit

July 12, 2012

SEATTLE--(BUSINESS WIRE)--July 12, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Monday, July 30, 2012, at 4:30 p.m. ET to review second quarter financial results. Access to the discussion...

July 12, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, July 25, 2012 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to...

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.13 per share. The dividend will be paid on...

July 12, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has rescheduled its annual meeting of stockholders to Tuesday, July 31, 2012, at 2:00...

July 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--IntegraGen announced today that the company has received €2 million in financing from funds managed by A Plus Finance to support development and marketing of genetic tests for autism and oncology.

July 12, 2012

NEW YORK CITY--(BUSINESS WIRE)--The James J. Peters Veterans Hospital in Bronx, New York, is actively recruiting participants for a phase IIb clinical trial testing NIC5-15, a disease modifying candidate for Alzheimer’s disease.

July 12, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in a Phase...

July 12, 2012

ZURICH & LUGANO, Switzerland--(BUSINESS WIRE)--The winners of the Fidelity Future Impact Prize were announced on Monday at the inaugural Partnering for Global Impact conference in Lugano, Switzerland. Sponsored by Fidelity Worldwide...

July 12, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces two key achievements in...

July 12, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its second quarter 2012 financial results at 4:00 p.m. ET on Thursday, July 19th, 2012. In connection with this announcement, Cubist will host a conference...

July 12, 2012

WASHINGTON--(BUSINESS WIRE)--Six biofuel trade organizations jointly petitioned the U.S. Court of Appeals for the District of Columbia Circuit to intervene with EPA in a lawsuit filed by petroleum refiners over the RFS

July 12, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its U.S....

July 12, 2012

WASHINGTON--(BUSINESS WIRE)--Ohio's bioscience industry organization to update state's Congressional delegation on growth, opportunities, and challenges

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) announced today that it has priced an underwritten public offering of 6.25 million shares of its common stock at a price to the public of $16 per share. Gross proceeds are expected...

July 12, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Rex Health Ventures, one of the nation’s only venture-capital funds managed by a community, nonprofit hospital, is pleased to announce its first investment, a $500,000 equity placement in Aerial BioPharma. Aerial,...

July 12, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the Seventh Annual JMP...

July 12, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation and Medtronic Surgical Technologies, a business unit of Medtronic Inc, announced the integration NeuroLogica’s portable BodyTomTM 32-slice CT scanner with Medtronic’s StealthStation® S7®...

July 12, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces PowerPlex(R) Y23 System, a human identification Y-STR assay for forensic casework, offender databasing and relationship testing.

July 12, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the opening of its Global Commercial Solutions business in Brazil, offering customized sales forces, market penetration strategies and product solutions.

July 12, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its third quarter of fiscal year...

July 12, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the initiation of its pivotal Phase 3 studies evaluating the efficacy and safety of CB-315 in patients with Clostridium difficile-associated diarrhea,...

July 12, 2012

CAMBRIDGE, Mass. & HANGZHOU, China & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Ascletis Pharmaceuticals (Hangzhou) Co., Ltd.., a privately held US...

July 12, 2012

DEERFIELD, Ill. & PALO ALTO, Calif.--(BUSINESS WIRE)--Takeda Pharmaceuticals U.S.A. (TPUSA) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda Pharmaceuticals America, Inc. (TPA) has entered into a supply agreement for sourcing and...

July 12, 2012

EXTON, Penn.--(BUSINESS WIRE)--According PatientTrends®: Crohn’s Disease, 13 percent of Crohn’s patients report requesting specific brands of Crohn’s medications for their disease treatment from their gastroenterologists.

July 12, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced top-line results from the PALACE-1 study, the first of three pivotal phase III, randomized, placebo-controlled...

July 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem discloses research results and updated clinical plans at its research and development day.

July 12, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has partnered with PRIDE Industries for distribution of the PURE Complete System...

July 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced a research collaboration with...

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today the appointment of...

July 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced a publication by company...

July 12, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--Following several years of slowing growth, the global market for medicines is poised to rebound from an expected low point of 3-4 percent growth in 2012 to 5-7 percent in 2016, according to a new forecast issued...

July 12, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 Ltd is pleased to announce that its CLIA laboratory in Greenville will be 1 of 9 US labs to offer the first FDA approved companion diagnostic to provide guidance for the use of Erbitux®

July 12, 2012

TOKYO--(BUSINESS WIRE)--We are pleased to announce that R-Tech Ueno (JASDAQ: 4573) will conduct a collaborative study with Tohoku University, a national university corporation, to develop a drug delivery system for Isopropyl Unoprostone (...

July 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem has acquired a clinical-stage FAK inhibitor from Pfizer. Verastem anticipates conducting clinical trials targeting solid tumor indications with the FAK inhibitor candidate, VS-6063.

July 11, 2012

JERSEY CITY, N.J.--(BUSINESS WIRE)--Medikly, Inc. (Medikly), a healthcare technology startup, announced today the availability of KONNECT, a cloud-based, next-generation engagement and analytics platform for pharmaceutical brand teams and...

July 11, 2012

REYKJAVIK, Iceland--(BUSINESS WIRE)--deCODE Genetics reported today in the journal Nature the discovery of a variant of a gene that confers protection against both Alzheimer’s disease and cognitive decline in the elderly.

July 11, 2012

MORGANTOWN, W. Va. & WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management and care coordination services to medical groups, announced today that they have contracted with...

July 11, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Names Dr. Matthew Strobeck
to Board of Directors

July 11, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Attached is a press release issued earlier today by GlaxoSmithKline, announcing that data have been received from the Phase 3 Harmony 8 study and from the event-driven meta-analysis for assessment of...

July 11, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced its decision to retain the Dreux (France)-based industrial facility within the scope of its activity. Considering the perspectives of Ipsen’s primary care...

July 11, 2012

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--This year, EBD Group’s BioPharm America™ will partner with Nature Publishing Group and BioCentury Publications Inc. to host the first SciBX: Science-Business eXchange Innovation in BioPharma Summit...

July 11, 2012

WASHINGTON--(BUSINESS WIRE)--The Agriculture Energy Coalition urges the House Agriculture Committee to include strong mandatory funding for energy programs as it marks up its version of the Farm Bill.